10-KRNTXCIK 0001420565

Rein Therapeutics, Inc.

Name: SEC EDGAR filing 0001193125-26-126385
Creator: Rein Therapeutics, Inc.
License: https://www.usa.gov/government-works

Annual report (10-K) filed March 26, 2026.

Comprehensive annual report filed by U.S. public companies, including audited financial statements, MD&A, and risk factors.

Read the filing on SEC.gov All documents in this filing

New to the 10-K? What it is and how to read one

Filing facts

Accession number: 0001193125-26-126385
Filer: Rein Therapeutics, Inc.
Ticker: RNTX
CIK: 0001420565
Form type: 10-K
Form description: Annual report
Filed at: March 26, 2026
Period of report: December 31, 2025
Industry: SIC 2834Pharmaceutical Preparations
Filing size: 13.0 MB
Last verified: August 26, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from Rein Therapeutics, Inc.

See all 41 filings from Rein Therapeutics, Inc. →

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1420565/000119312526126385/0001193125-26-126385-index.htm ↗

Filer's full EDGAR submission history

EDGAR · Rein Therapeutics, Inc. (0001420565) ↗

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.